Holen Sie sich die Stockscreener-App
13.60
1.02%
-0.14
Handel nachbörslich:
13.60
Schlusskurs vom Vortag:
$13.74
Offen:
$14
24-Stunden-Volumen:
299.06K
Relative Volume:
2.49
Marktkapitalisierung:
$595.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.56%
1M Leistung:
-9.63%
6M Leistung:
+20.14%
1J Leistung:
+0.00%
1-Tages-Spanne:
$13.16
$14.56
1-Wochen-Bereich:
$12.89
$14.56
52-Wochen-Spanne:
$6.71
$18.67
Maze Therapeutics Inc Stock (MAZE) Company Profile
Firmenname
Maze Therapeutics Inc
Sektor
Branche
Telefon
(650) 850-5070
Adresse
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Vergleichen Sie MAZE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MAZE
Maze Therapeutics Inc
|
13.60 | 589.95M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-08 | Eingeleitet | Wedbush | Outperform |
Maze Therapeutics Inc Aktie (MAZE) Neueste Nachrichten
Maze Therapeutics, Inc.: Buy Rating Backed by Promising Clinical Developments and Strategic Trials - TipRanks
What’s the recovery path for long term holders of Maze Therapeutics Inc.Quarterly Portfolio Summary & Weekly High Return Stock Opportunities - Newser
Maze Therapeutics: Promising Innovations in PKU and CKD Treatment with MZE782 - TipRanks
Risk adjusted return profile for Maze Therapeutics Inc. analyzedWeekly Stock Recap & Consistent Growth Equity Picks - Newser
Should you wait for a breakout in Maze Therapeutics Inc.Oil Prices & High Return Trade Opportunity Guides - Newser
How Maze Therapeutics Inc. stock performs during market volatility2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Why Maze Therapeutics Inc. stock attracts strong analyst attentionQuarterly Trade Review & Risk Controlled Daily Plans - Newser
Using data models to predict Maze Therapeutics Inc. stock movement - Newser
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights - GlobeNewswire
How to escape a deep drawdown in Maze Therapeutics Inc.Free Real Market Momentum Signal Generator - Newser
Is it time to cut losses on Maze Therapeutics Inc.Free Fast Gaining Stock Screener Report - Newser
Will Maze Therapeutics Inc. stock recover after earningsExploding Volume High ROI Picks - newsyoung.net
Institutional scanner results for Maze Therapeutics Inc.Free Buy Alerts With Low Risk Confirmation - Newser
Maze Therapeutics reports Q2 EPS (77c), consensus ($1.15) - TipRanks
When is the best time to exit Maze Therapeutics Inc.Technical Chart Summary for Momentum Stocks - Newser
Published on: 2025-08-12 08:41:52 - Newser
Will a bounce in Maze Therapeutics Inc. offer an exitBuy and Hold Strategy for Capital Safety - Newser
What moving averages say about Maze Therapeutics Inc.Profit Target Planning with Exit Confidence - Newser
How to build a custom watchlist for Maze Therapeutics Inc.Real Market Tracker with Price Action Tools - Newser
What makes Maze Therapeutics Inc. stock price move sharplyStock Entry Point Planner with Volume Spike - Newser
Visual trend scoring systems applied to Maze Therapeutics Inc.Portfolio Risk Distribution Analysis Tool - Newser
Real time pattern detection on Maze Therapeutics Inc. stockFree Risk-Adjusted Picks With Exit Strategy - Newser
Bank of New York Mellon Corp Makes New Investment in Maze Therapeutics, Inc. (NASDAQ:MAZE) - Defense World
Maze Therapeutics, Inc. (NASDAQ:MAZE) Receives $25.60 Average Price Target from Analysts - Defense World
How does Maze Therapeutics Inc. compare to its industry peersFast-track wealth growth - Jammu Links News
What are the technical indicators suggesting about Maze Therapeutics Inc.Invest confidently with real-time market updates - Jammu Links News
How volatile is Maze Therapeutics Inc. stock compared to the marketDiscover top stock picks for aggressive growth - Jammu Links News
What institutional investors are buying Maze Therapeutics Inc. stockFree Stock Market Forecast Reports - Jammu Links News
What are analysts’ price targets for Maze Therapeutics Inc. in the next 12 monthsInvest confidently with advanced analysis tools - Jammu Links News
What drives Maze Therapeutics Inc. stock priceCapitalize on emerging market opportunities - Jammu Links News
Is Maze Therapeutics Inc. a growth stock or a value stockBuild wealth steadily with proven stock picks - Jammu Links News
Is Maze Therapeutics Inc. stock overvalued or undervaluedUnlock exclusive stock market insights - Jammu Links News
Is Maze Therapeutics Inc. stock poised for growthFree Alpha Driven Watchlist With Alerts - Newser
Why is Maze Therapeutics Inc. stock attracting strong analyst attentionUnmatched profit potential - Jammu Links News
What are the latest earnings results for Maze Therapeutics Inc.High-profit capital plays - Jammu Links News
What is Maze Therapeutics Inc. company’s growth strategyWealth Building Planner With Proven Results - jammulinksnews.com
Finanzdaten der Maze Therapeutics Inc-Aktie (MAZE)
Es liegen keine Finanzdaten für Maze Therapeutics Inc (MAZE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):